Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep411 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Inpatient glycaemic variability and long-term mortality: a neglected diabetic parameter?

Timmons Joseph , Jones Gregory , Sainsbury Christopher , Cunningham Scott

Aim: To determine the association between recorded inpatient glycaemic variability and long-term mortality in patients with diabetes mellitus.Methods: Inpatient capillary blood glucose (CBG) readings from eight acute hospitals were included. Data was analysed from first admission within the dataset with >4 measured CBGs. 28 353 admissions were identified (24 181 type 2 DM, 4,172 type 1 DM). Matching parameters were: age, diabetes duration, admission ...

ea0039oc5.8 | Oral Communications 5 | BSPED2015

Neonatal TSH: is it useful and appropriate as an indicator of iodine insufficiency in the UK?

Sharif Sahar , Jones Jeremy , Smith Sarah , Combet Emilie

Introduction: The World Health Organisation (WHO) states that in an iodine sufficient population <3% of neonatal TSH values will exceed 5 mU/l. In Belgium and Wales 2.6 and 1.5% of values were above 5 mU/l respectively.Methods: Neonatal TSH (neoTSH) levels (AutoDELFIA fluoroimmunoassay, 2006–2013, Scotland) were analysed for prevalence of high value according to cut-off, season and feeding mode (IBM SPSS 22).Results: Out o...

ea0039ep48 | Diabetes | BSPED2015

Use of U200 insulin degludec (Tresiba) and metformin in an adolescent with Type-1 diabetes-mellitus

Bhushan Arya Ved , Newland-Jones Philip , Trevelyan Nicola

Background: Insulin dose requirements are higher during puberty and in overweight/obese individuals with type 1 diabetes mellitus (T1DM) due to insulin resistance. Through meta-analysis metformin has been shown to be beneficial as adjunctive therapy in T1DM adults independent of BMI. The large volumes of insulin required to administer higher insulin doses in insulin-resistant individuals have adverse effects on insulin absorption. Insulin degludec (Tresiba) U200 preparation al...

ea0038p27 | Clinical biochemistry | SFEBES2015

Turn off the taps

Jones Sophie , Alexander Mariam , Hilton Christopher , Mehta Sanjeev

A 85-year-old man presented with a 2-week history of malaise, confusion and agitation and 4 weeks of polydipsia and polyuria, with water intake of 6 l/day. His past medical history included hypertension, congestive cardiac failure, and chronic kidney disease. On examination he was hypervolaemic. Initial investigations were as follows: serum sodium 115 mmol/l, potassium 4.6 mmol/l, urea 8.1 mmol/l (2.5–7.8), creatinine 138 μmol/l (66–112), serum osmolality 245 mO...

ea0038p46 | Clinical practice/governance and case reports | SFEBES2015

Review in specialist Turner clinic improves management

Packer Caroline , Jones Christopher , Clift Paul , Toogood Andrew

Background: Turner syndrome (TS) is associated with significant morbidity and a reduction in life expectancy. National guidelines have been developed to support the management of adult patients with TS but little is known about their implementation. We therefore sought to compare the management of patients with TS seen within a single tertiary referral centre by endocrinology, either general-purpose or Turner-specific clinics (TSC), or by other specialties.<p class="abstex...

ea0038p88 | Clinical practice/governance and case reports | SFEBES2015

Haemofiltration as a treatment option in refractory life-threatening diabetic ketoacidosis

Agha Adnan , Nawaz Sarfraz , Saleem Mazhar , Jones Sharon , Ahmed Adeeba

Background: Treating life-threatening diabetic ketoacidosis (DKA) with a pH of <6.9 is extremely challenging and often refractory to treatment using standard fixed dose insulin DKA management protocols which may not work effectively at this low pH because of increased insulin resistance. I.v. bicarbonate (HCO3) use in this situation can be considered but remains controversial due to the risk of significant side effects as well as limited evidence in literature. ...

ea0038p93 | Clinical practice/governance and case reports | SFEBES2015

Evaluation of use of combination dapagliflozin and GLP1 agonist treatment in type 2 diabetes

Hayden Jennifer , Huang Feicong , McConnell Lyndsey , Sainsbury Christopher , Jones Gregory

Background: Dapagliflozin was the first SGLT2 inhibitor licensed in UK to improve glycaemic control in type 2 diabetes. Whilst it has not been studied for use in combination with GLP1 agonists the modes of action of the two therapies suggest they would be a logical therapeutic combination. We aimed to evaluate clinical experience with this regimen.Methods: Observational retrospective data was collected from electronic patient records (SCI–diabetes) ...

ea0038p107 | Clinical practice/governance and case reports | SFEBES2015

Opiate induced multiple pituitary hormone deficits

Sabin Jodie , Jones Ginette , Barwick Catrin , Wilton Anthony

Opiate use is a well-recognised cause of hypogonadotrophic hypogonadism. Adrenocorticotrophic hormone and growth hormone deficiencies are much rarer.A 56-year-old female presented with weight loss, lethargy, and nausea of ~3 years duration. She had received treatment with morphine sulphate 100 mg twice daily for ~15 years for back pain due to disc prolapse and osteoarthritis. A 0900 h cortisol of 110 nmol/l requested by her general practitioner had resul...

ea0038p178 | Nursing practise | SFEBES2015

Pre-pituitary surgery patient satisfaction audit 2015

Thornton-Jones Vivien , Turner Helen , Cudlip Simon , Grossman Ashley

Background: Pre-pituitary surgery, patients attend a ‘Pre-Pituitary Surgery Clinic’ (PPSC), to discuss management options and risks. Clinicians in attendance are; pituitary surgeon (1) registrar (1) endocrine team consultants (1–3), registrars (1–2) nurses (1) senior house officer (1) visiting doctors/medical students (4–6). Patients are informed a number of clinicians attend the clinic due to the multidisciplinary nature (MDT) and unit teaching respon...